WELCOME TO CLL PHARMACIST
Chronic Lymphocytic Leukemia (CLL)
My team and I created this site to provide knowledge to CLL patients and their caregivers.
IN MEMORY OF THOMAS HENRY, CLL PHARMACIST
Lt. Col. (Ret.) Thomas E. Henry III, 72, passed away February 9, 2022 unexpectedly from complications of COVID.
The Latest Trends IN CLL CARE

Have we met yet?
I’m Thomas E. Henry III, MBA, RPh, CPh
When you or a loved one was diagnosed with Chronic Lymphocytic Leukemia (CLL), did you do research? Did you start with Google? That’s what I did and I quickly learned that not all information is reliable.
I want to be one of the sources you turn to first. Not just because I’ve been a pharmacist for 41-years but, because, like YOU, I am a CLL patient since 2015.
Did you initially feel overwhelmed, afraid, and didn’t know where to turn for information, or are you an “old-hand” at CLL and just looking for additional information? I want to share the knowledge I’ve gained, as a patient, healthcare provider, and a CLL patient-advocate, to lessen the burden for you.
Here’s What I believe:
- Together, we can take the fear out of CLL through education and knowledge.
- You and I have control over our life and our care. I hope that you, like me, have vowed that allowing this to “just happen” or “control us” is NOT AN OPTION.
- There is power in a team and more power in a community, and you and I benefit when we interact with others who have the same challenge.
- When we present a confident demeanor, backed by information, our healthcare-team responds with better care, customized to meet our individual needs.
- I created this site out of my desire to help fellow patients. I make no money from this endeavor.
Here’s How I Got Started
Like many patients, the first news that something was amiss came when I went for my routine annual physical and my White Blood Cell (WBC) count was elevated. My physician’s assistant immediately suspected CLL.
Because I had recently been to South America, my doctor ran a blood test to check for malaria. The first test was positive, and I thought “malaria is probably better than cancer”. In the second test, a DNA test, used to confirm the initial test the result was negative and showed it was not malaria.
Have you experienced an initial misdiagnosis? If I hadn’t had the second test, I might have! READ MORE HERE!
Recent Posts
The treatment of CLL has changed dramatically in just the last 7-10 years. CLL information, journal articles and clinical trials data are expanding exponentially. Here are our most recent blog posts. For more information, visit the blog page or use the search tool in the header on each page. We welcome your comments, suggestions and feedback!
EVUSHELD™ May Protect CLL/SLL Patients From COVID-19
Exciting News – FDA Grants Emergency Use Authorization for First COVID Monoclonal Antibody for Pre-Exposure Prevention of COVID for CLL/SLL Patients and Others at Risk!On December 8, 2021, the United States (US) Food and Drug Administration (FDA) issued an Emergency...
ACE-CL-001 Studies Acalabrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia (CLL)
ACE-CL-001 Studies Acalabrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia (CLL)In several recent posts, we covered the use of acalabrutinib in patients with relapsed/refractory chronic lymphocytic leukemia. This week, we switch gears with a review of the phase...
ACE-CL-208 – A Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory CLL
CLL Research: ACE-CL-208 – A Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory CLLACE-CL-208 is a phase 2 clinical trial of acalabrutinib in ibrutinib-intolerant and had relapsed (returned)/refractory (didn’t respond to prior...